InterCure Ltd.
INCR

$68.19 M
Marketcap
$1.49
Share price
Country
$0.15
Change (1 day)
$3.72
Year High
$1.17
Year Low

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

marketcap

Revenue of InterCure Ltd. (INCR)

Revenue in 2023 (TTM): $355.55 M

According to InterCure Ltd.'s latest financial reports the company's current revenue (TTM) is $355.55 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of InterCure Ltd.

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $355.55 M $105.1 M $-23,900,000 $-61,285,000 $-61,959,000
2022 $388.68 M $155.08 M $64.5 M $43.84 M $44.82 M
2021 $219.68 M $91.13 M $37.45 M $18.74 M $7.3 M
2020 $65.04 M $31.98 M $-34,527,000 $-38,308,000 $-36,040,000
2019 $8.93 M $1.48 M $-21,204,000 $-3,669,000 $-2,996,000
2018 $ $ $-10,124,000 $-12,798,000 $-12,798,000
2017 $ $ $-1,091,338 $-5,258,583 $-5,258,583
2016 $ $ $ $265.42 K $265.42 K
2015 $1.4 M $862.71 K $-1,639,537 $-1,877,660 $-1,877,660
2014 $5.65 M $3.78 M $-3,769,324 $-3,792,688 $-3,792,688
2013 $8.25 M $6.41 M $-1,880,550 $-6,606,303 $-6,606,303
2012 $8.47 M $6.47 M $45.38 M $43.44 M $43.44 M
2011 $12.07 M $9.18 M $-1,647,998 $-6,759,456 $-6,801,322
2010 $13.23 M $10.1 M $-4,598,195 $-12,517,309 $-12,563,433